News from the FDA/CDC

FDA authorizes Pfizer antiviral pill for COVID-19

Publish date: December 22, 2021

 

A version of this article first appeared on WebMD.com.

Pages

Recommended Reading

CDC supports ‘test-to-stay’ for COVID- exposed students
MDedge Infectious Disease
Emergency docs cite ‘dire’ situation as COVID grows, nurses scarce
MDedge Infectious Disease
Axilla swelling after COVID booster puts focus on mammogram timing
MDedge Infectious Disease
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
MDedge Infectious Disease
RSV resurgence likely in wake of COVID-19
MDedge Infectious Disease
Children and COVID: New cases up slightly, vaccinations continue to slow
MDedge Infectious Disease
Bamlanivimab’s effects in COVID-19 depend on antibodies
MDedge Infectious Disease
Convalescent plasma cuts COVID-19 hospitalizations in half: Study
MDedge Infectious Disease
GI symptoms in kids with COVID may predict severe outcomes
MDedge Infectious Disease
Pandemic poses short- and long-term risks to babies, especially boys
MDedge Infectious Disease